Skip to content
Home/Companies/MedTech/Seyond
SE

Seyond

MedTech·China·Exited 2024·Held 6yr

Seyond is a MedTech company, headquartered in China.

Entry
2018
Hold
6yr
Exit
2024
Est. EV
–

Who owns Seyond?

Seyond was owned by Bertelsmann Investments through Bertelsmann Asia Investments (BAI) (2008 vintage) from 2018 to 2024, exited via IPO.

Hand-verified · updated 2026-07-07

Bertelsmann Investments
Investor
Bertelsmann Investments
Bertelsmann Asia Investments (BAI) · 2008 · VC

Key facts

HQChina
SectorMedTech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2024

More from Bertelsmann Asia Investments (BAI)

Other portfolio companies in the same fund.

Stori
Active
FintechMexico· 2020
Deepexi
Exited 2025
SoftwareChina· 2018
NetEase Cloud Music
Exited 2021
TMTChina· 2018
Mobike
Exited 2018
MobilityChina· 2016
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings